Bank of Montreal Can bought a new position in shares of Hill-Rom Holdings Inc. (NYSE:HRC) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 306,902 shares of the medical technology company’s stock, valued at approximately $15,483,000.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Capstone Asset Management Co. boosted its position in Hill-Rom Holdings by 4.2% in the second quarter. Capstone Asset Management Co. now owns 7,225 shares of the medical technology company’s stock worth $365,000 after buying an additional 290 shares during the period. Envestnet Asset Management Inc. boosted its position in Hill-Rom Holdings by 30.1% in the first quarter. Envestnet Asset Management Inc. now owns 2,454 shares of the medical technology company’s stock worth $123,000 after buying an additional 568 shares during the period. IBM Retirement Fund boosted its position in Hill-Rom Holdings by 16.4% in the second quarter. IBM Retirement Fund now owns 6,611 shares of the medical technology company’s stock worth $334,000 after buying an additional 931 shares during the period. Legal & General Group Plc boosted its position in Hill-Rom Holdings by 19.2% in the first quarter. Legal & General Group Plc now owns 6,459 shares of the medical technology company’s stock worth $324,000 after buying an additional 1,042 shares during the period. Finally, Aperio Group LLC boosted its position in Hill-Rom Holdings by 11.1% in the first quarter. Aperio Group LLC now owns 12,062 shares of the medical technology company’s stock worth $607,000 after buying an additional 1,207 shares during the period. Institutional investors own 83.11% of the company’s stock.
Hill-Rom Holdings Inc. (NYSE:HRC) traded up 1.67% during mid-day trading on Friday, hitting $61.98. 427,134 shares of the stock were exchanged. Hill-Rom Holdings Inc. has a 52-week low of $42.99 and a 52-week high of $62.17. The stock has a market cap of $4.06 billion, a PE ratio of 63.83 and a beta of 1.06. The stock’s 50 day moving average is $59.32 and its 200 day moving average is $52.93.
Hill-Rom Holdings (NYSE:HRC) last released its quarterly earnings data on Thursday, August 4th. The medical technology company reported $0.81 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.76 by $0.05. The firm had revenue of $655.40 million for the quarter, compared to analyst estimates of $647.75 million. Hill-Rom Holdings had a net margin of 2.47% and a return on equity of 16.62%. The business’s quarterly revenue was up 38.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.62 earnings per share. Analysts forecast that Hill-Rom Holdings Inc. will post $3.33 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 30th. Stockholders of record on Friday, September 16th were paid a $0.17 dividend. The ex-dividend date of this dividend was Wednesday, September 14th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.10%. Hill-Rom Holdings’s payout ratio is currently 73.91%.
A number of research firms recently weighed in on HRC. Zacks Investment Research upgraded shares of Hill-Rom Holdings from a “hold” rating to a “buy” rating and set a $64.00 target price on the stock in a research note on Tuesday, August 9th. KeyCorp reiterated a “buy” rating and issued a $59.00 price target on shares of Hill-Rom Holdings in a research note on Thursday, June 23rd. Finally, Morgan Stanley upgraded shares of Hill-Rom Holdings from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $54.00 to $62.00 in a research note on Thursday, June 16th. Five research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $61.83.
Hill-Rom Holdings Company Profile
Hill-Rom Holdings, Inc is a medical technology company. The Company offers patient care solutions that improve clinical and economic outcomes in advancing mobility, wound care and prevention, clinical workflow, surgical safety and efficiency, and respiratory health areas. Its segments include North America, Surgical and Respiratory Care, International and Welch Allyn.
Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings Inc. (NYSE:HRC).
Receive News & Ratings for Hill-Rom Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.